---
figid: PMC7227439__fphar-11-00635-g001
figtitle: Role of metformin in VSMCs dysfunction
organisms:
- Mus musculus
- Rattus norvegicus
- Cavia porcellus
- Homo sapiens
- Canis lupus familiaris
- Galega officinalis
organisms_ner:
- Homo sapiens
- Mus musculus
- Cavia porcellus
- Rattus norvegicus
- Canis lupus familiaris
- Drosophila melanogaster
pmcid: PMC7227439
filename: fphar-11-00635-g001.jpg
figlink: pmc/articles/PMC7227439/figure/f1/
number: F1
caption: 'Role of metformin in VSMCs dysfunction. Metformin exerts its function of
  improving the function of VSMCs by regulating the expression and function of genes
  or proteins closely related to VSMCs proliferation and migration, calcification,
  contraction, and inflammation. ↑indicates increase or activation, and ↓indicates
  decrease or suppression. Metformin inhibits VSMCs proliferation: 1. Activates AMPK,
  inhibits mTOR, down-regulates Skp2 while up-regulates p27. 2. Up-regulates expression
  of PGC-1β. 3. Activates AMPK, reduces HA synthesis. 4. Activates AMPK, up-regulates
  P53 and IFI16. Metformin inhibits vascular calcification: 1. Activates AMPKα1 and
  inhibits Runx2 expression. 2. Activates the AMPK-eNOS-NO pathway. 3. Enhances mitochondrial
  biogenesis and inhibits PDK4/oxidative stress-mediated apoptotic pathway. Metformin
  inhibits smooth muscle contraction: 1. Enhances insulin sensitivity and inhibits
  methylglyoxal activation of renin angiotensin system. 2. Inhibits the rise of [Ca2+]i
  and [K+]i in VSMCs. Metformin inhibits inflammation: 1. Activates AMPK and up-regulates
  PTEN expression. 2. Inhibits PI3K-Akt and NF-κB activation. 3. Up-regulates the
  expression of PGC-1α.'
papertitle: 'Metformin and Vascular Diseases: A Focused Review on Smooth Muscle Cell
  Function.'
reftext: Mingying Deng, et al. Front Pharmacol. 2020;11:635.
year: '2020'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.7494943
figid_alias: PMC7227439__F1
figtype: Figure
redirect_from: /figures/PMC7227439__F1
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC7227439__fphar-11-00635-g001.html
  '@type': Dataset
  description: 'Role of metformin in VSMCs dysfunction. Metformin exerts its function
    of improving the function of VSMCs by regulating the expression and function of
    genes or proteins closely related to VSMCs proliferation and migration, calcification,
    contraction, and inflammation. ↑indicates increase or activation, and ↓indicates
    decrease or suppression. Metformin inhibits VSMCs proliferation: 1. Activates
    AMPK, inhibits mTOR, down-regulates Skp2 while up-regulates p27. 2. Up-regulates
    expression of PGC-1β. 3. Activates AMPK, reduces HA synthesis. 4. Activates AMPK,
    up-regulates P53 and IFI16. Metformin inhibits vascular calcification: 1. Activates
    AMPKα1 and inhibits Runx2 expression. 2. Activates the AMPK-eNOS-NO pathway. 3.
    Enhances mitochondrial biogenesis and inhibits PDK4/oxidative stress-mediated
    apoptotic pathway. Metformin inhibits smooth muscle contraction: 1. Enhances insulin
    sensitivity and inhibits methylglyoxal activation of renin angiotensin system.
    2. Inhibits the rise of [Ca2+]i and [K+]i in VSMCs. Metformin inhibits inflammation:
    1. Activates AMPK and up-regulates PTEN expression. 2. Inhibits PI3K-Akt and NF-κB
    activation. 3. Up-regulates the expression of PGC-1α.'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - PRKAA1
  - PRKAA2
  - PRKAB1
  - PRKAB2
  - PRKAG1
  - PRKAG2
  - PRKAG3
  - AKT1
  - AKT2
  - AKT3
  - PIK3CA
  - PIK3CB
  - PIK3CD
  - PIK3CG
  - PIK3R3
  - PIK3R4
  - PIK3R5
  - PIK3R6
  - PIK3R1
  - PIK3R2
  - NFKB1
  - MTOR
  - RORC
  - SKP2
  - UXT
  - IFI27
  - PSMD9
  - ZNRD2
  - DCTN6
  - TMED7
  - H3P23
  - TP53
  - TP63
  - TP73
  - IFI16
  - CA1
  - RUNX2
  - NOS3
  - ENO4
  - PDK4
  - Akt1
  - Pik3r1
  - Nfkb1
  - Prkaa1
  - Mtor
  - tor
  - Rorc
  - Skp2
  - Cdkn1b
  - Dctn6
  - Psmd9
  - Trp53
  - Ifi204
  - Pdia4
  - Runx2
  - Nos3
  - Pdk4
  - Tp53
  - Ifi16
  - Prkaa2
  - Pik3cg
  - Tmed7
  - Car1
  - CDKN1B
  - LOC488622
  - SNF4Agamma
  - AMPKalpha
  - Akt
  - Pi3K21B
  - Pi3K59F
  - Pi3K68D
  - Pi3K92E
  - Dif
  - dl
  - Rel
  - Tor
  - Egfr
  - DCTN6-p27
  - dap
  - CG9588
  - ha
  - p53
  - betaTub60D
  - hth
  - Ki
  - CkIIbeta
  - Andorra
  - Anp
  - Acam
  - Metformin
  - Methylglyoxal
  - Ca
  - 'NO'
  - calcification
---
